Welcome : Guest

MyoKardia, Inc. (USA) - Facts, Figures and Analytical Insights


This report presents quick facts about MyoKardia, Inc., which is principally involved in Clinical-Stage Biopharmaceuticals Business. Illustrated with 5 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-66208
Price: $250
Company Type: Public
Pages: 8
Date: November 2016
Market Data Tables: 5

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Cardio Vascular Diseases (CVD)......4
Table 1: Cardio Vascular Diseases (CVD) Market by Cause of Death in the US (2015) - Percentage Share Breakdown by Volume for Coronary Heart Disease, Diseases of the Arteries, Heart Failure, High Blood Pressure, Stroke, and Others......4
Cardiology Therapeutics......5
Table 2: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......5
Table 3: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......6
Table 4: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......7
Cardiology Therapeutics......8
Table 5: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......8